Molecular Imaging - a way forward in translating disease behaviour in an era of personalized medicine.
作者信息
Fathinul Fikri A S
机构信息
Centre for Diagnostic Nuclear imaging, Universiti Putra Malaysia Serdang Selangor, Malaysia.
出版信息
J Int Med Res. 2018 Feb;46(2):652-653. doi: 10.1177/0300060517719211. Epub 2017 Jul 18.
Abstract
摘要
相似文献
1
Molecular Imaging - a way forward in translating disease behaviour in an era of personalized medicine.
J Int Med Res. 2018 Feb;46(2):652-653. doi: 10.1177/0300060517719211. Epub 2017 Jul 18.
2
Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer.
Contrast Media Mol Imaging. 2019 Jul 1;2019:9429761. doi: 10.1155/2019/9429761. eCollection 2019.
3
From pure research imaging tool to PET-guided personalized medicine in oncology: a true revolution in modern medicine.
Indian J Cancer. 2010 Apr-Jun;47(2):98-9. doi: 10.4103/0019-509X.62994.
4
Radionuclide Therapies in Molecular Imaging and Precision Medicine.
PET Clin. 2017 Jan;12(1):93-103. doi: 10.1016/j.cpet.2016.08.006. Epub 2016 Sep 19.
5
Molecular imaging-its current role in cancer.
QJM. 2016 May;109(5):295-9. doi: 10.1093/qjmed/hcv141. Epub 2015 Aug 7.
6
Functional MR Imaging Techniques in Oncology in the Era of Personalized Medicine.
Magn Reson Imaging Clin N Am. 2016 Feb;24(1):1-10. doi: 10.1016/j.mric.2015.08.001. Epub 2015 Sep 26.
7
Editorial.
Clin Radiol. 2017 Jan;72(1):1-2. doi: 10.1016/j.crad.2016.10.002. Epub 2016 Nov 9.
8
Companion Diagnostics and Molecular Imaging.
Cancer J. 2015 May-Jun;21(3):213-7. doi: 10.1097/PPO.0000000000000110.
9
Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Drug Resist Updat. 2016 Jul;27:39-58. doi: 10.1016/j.drup.2016.06.003. Epub 2016 Jun 16.
10
Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
PET Clin. 2017 Jan;12(1):105-118. doi: 10.1016/j.cpet.2016.08.002. Epub 2016 Oct 5.
引用本文的文献
1
The Role of Molecular Imaging in Personalized Medicine.
J Pers Med. 2023 Feb 19;13(2):369. doi: 10.3390/jpm13020369.
2
The Utilization of Autoantibodies in Approaches to Precision Health.
Front Immunol. 2018 Nov 16;9:2682. doi: 10.3389/fimmu.2018.02682. eCollection 2018.
本文引用的文献
1
Changing paradigms with molecular imaging of neuroendocrine tumors.
Discov Med. 2012 Jul;14(74):71-81.
2
18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology.
Cell Biochem Biophys. 2013 May;66(1):37-43. doi: 10.1007/s12013-012-9395-5.
Zotero 插件